News

The company reported strong earnings in the second quarter of 2025. It posted revenue of $11.1 billion, which showed a 7.37% ...
We came across a bullish thesis on Abbott Laboratories on r/ValueInvesting subreddit by anonymous_sheep1. In this article, we ...
Abbott Laboratories CEO Robert Ford unpacked his company’s latest quarterly report in a Thursday interview with CNBC’s Jim ...
Today, in an otherwise positive market, I was discouraged to get a mixed update from Abbott Labs, medical technology company ...
We recently published Jim Cramer Discusses These 10 Stocks & AI-Led Disinflation. Abbott Laboratories (NYSE:ABT) is one of ...
Abbott Laboratories ABT is preparing to release its quarterly earnings on Thursday, 2025-07-17. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...
Explore more
Abbott posted Q2 revenue of $11.14 billion and EPS of $1.26, raised 2025 earnings guidance, and saw strong growth in diabetes ...
Abbott Laboratories closed 6.52% below its 52-week high of $141.23, which the company reached on March 4th.
Abbott Laboratories closed 14.67% below its 52-week high of $141.23, which the company achieved on March 4th.
The healthcare-products maker trimmed and narrowed its guidance for the year while reporting strong profit and sales gains in the second quarter.
Global healthcare leader Abbott Nutrition awarded Continental Express, Inc. its 2024 Truckload Provider of the Year Award at ...
"Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly ...